{ oral cancer early diagnostic and treatment professor igor reshetov p.a.hertzen cancer research...
TRANSCRIPT
![Page 1: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/1.jpg)
{{
Oral CancerOral CancerEarly diagnostic Early diagnostic and Treatmentand Treatment
Professor Igor ReshetovProfessor Igor Reshetov
P.A.Hertzen Cancer Research InstituteP.A.Hertzen Cancer Research Institute
MoscowMoscow
www.headneckonco.ruwww.headneckonco.ru
![Page 2: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/2.jpg)
Squamous cell carcinoma of the head and neck
(SCCHN): 98 000 new cases in Europe annually
SCCHN: mortality in Europe is 43 000
annually
SCCHN accounts for
6% of all malignancies
Worldwide annual incidence of SCCHN:
485 000 new patients; 261 000
deaths
Epidemiology of Epidemiology of SCCHNSCCHN
GLOBOCAN 2002 (http://www-dep.iar.fr)
![Page 3: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/3.jpg)
{{J.Shah 2012J.Shah 2012
Etiology factors in oral Etiology factors in oral cancercancer
![Page 4: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/4.jpg)
Reasons for Reasons for early early diagnostic diagnostic oral canceroral cancer
![Page 5: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/5.jpg)
{{J.Shah 2012J.Shah 2012
Pathogeneses oral cancer Pathogeneses oral cancer and depends T(tumor)) and depends T(tumor)) and N (metastases) and N (metastases) factorsfactors
![Page 6: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/6.jpg)
{{J.Shah 2012J.Shah 2012
Rate of survival in Rate of survival in depend with T(tumor) depend with T(tumor) factor factor
![Page 7: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/7.jpg)
{{J.Shah 2012J.Shah 2012
Survival in depend Survival in depend with N(metastases) with N(metastases) factorfactor
![Page 8: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/8.jpg)
{{Sloan-Kettering Cancer Center 2012Sloan-Kettering Cancer Center 2012
Survival in Survival in depend with depend with location of tumorlocation of tumor
![Page 9: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/9.jpg)
Methods of early Methods of early diagnostic oral diagnostic oral cancercancer
![Page 10: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/10.jpg)
{{
Possibilities ultra=scope in Possibilities ultra=scope in compare with light compare with light endoscopyendoscopy
![Page 11: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/11.jpg)
{{
White light endoscopy and fluoroscopy – White light endoscopy and fluoroscopy – correct vision margins and areacorrect vision margins and area
Different view in oral Different view in oral mucosa mucosa
![Page 12: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/12.jpg)
{{Mechanism of spectroscope oral Mechanism of spectroscope oral mucosamucosa
![Page 13: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/13.jpg)
Confocal laser microscopy
New method of morphological diagnostic in vivo tumors on skin and mucosa sensitivity - 88,5%Specifity – 97,6%
![Page 14: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/14.jpg)
Strategy of treatment Strategy of treatment – innovation new – innovation new technologiestechnologies
![Page 15: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/15.jpg)
{{Sloan-Kettering Cancer CenterSloan-Kettering Cancer CenterRate of survival in Rate of survival in depend with depend with possibilities of possibilities of combine combine treatmenttreatment
![Page 16: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/16.jpg)
Breast cancer(early, metastatic)
Bev, TZB, LAP..
Colo rectal ca(metastatic)
Bev, CET, PAN
NSCLC(metastatic)Bevacizumab
Renal cancer(metastatic)
Bev, sunitynib, ewerolimusSorafenib, TEMSR,
HCC(advanced)sorafenib
GISTImatinib
Molecularly targeted agents in oncology
Gastric cancer(metastatic)
TZB
Brain tumors(advanced)
Bev
Pancreatic ca(metastatic)
erlotinib
HNSCC(advanced)
CET
![Page 17: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/17.jpg)
EGFR InhibitorsEGFR Inhibitors Gefitinib (TKI)- NSCLCGefitinib (TKI)- NSCLC Erlotinib (TKI)- NSCLC, Erlotinib (TKI)- NSCLC,
pancreatic capancreatic ca Cetuximab (MAB)- colorectal Cetuximab (MAB)- colorectal
ca, head and neck ca, head and neck squamous cell ca, NSCLCsquamous cell ca, NSCLC
Panitumumab (MAB)- Panitumumab (MAB)- colorectal cacolorectal ca
New agentsNew agents
EGFR Receptor
Ryc. Materiały informacyjne Amgen
![Page 18: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/18.jpg)
Intraoperative radiotherapy
Photodynamic diagnostic and therapy Electrochemical lysis
Definition of sentry lymph node
Technologies in surgical oncologyTechnologies in surgical oncology
![Page 19: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/19.jpg)
Clinic example P-t С. 16 year.Clinic example P-t С. 16 year.Diagnosis : recurrent pappilomas of larynx Diagnosis : recurrent pappilomas of larynx with displasia 3 grade with displasia 3 grade
Result – 5 years full remission
Electroresection
PDD (5Аla)
Nd:YAG laser
Befor treatment
Combine treatment
1 year after.
Splan cell pappilomas / ВПЧ 6 + 11 типы
![Page 20: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/20.jpg)
Robotic-assisted surgeryRobotic-assisted surgery
Da Vinci robot–assisted endocrine surgery: Novel
applications in otolaryngology
Neil Tanna, MD, Arjun S. Joshi, MD, Robert S. Glade, MD,
Daniel Zalkind, BS, and Nader Sadeghi, MD, Washington, DC
Otolaryngology–Head and Neck Surgery (2006) 135, 633-635
![Page 21: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/21.jpg)
TORS accessTORS access
Transoral robotic surgery
Neil G. Hockstein, MD,a,b Bert W. O’Malley, Jr, MDbOperative Techniques in Otolaryngology (2008) 19, 67-71
![Page 22: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/22.jpg)
Advantages of Advantages of TORSTORS
Trans cervical surgery with trocards of robotic laparoscopic
surgery
Better orientation and exposition of the tools :Possible surgery of the
hypopharynx
![Page 23: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/23.jpg)
Aim – total Aim – total survival more survival more 90 %90 %
![Page 24: { Oral Cancer Early diagnostic and Treatment Professor Igor Reshetov P.A.Hertzen Cancer Research Institute Mosco](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56649e9d5503460f94b9e437/html5/thumbnails/24.jpg)
{{Thank your Thank your AttentionAttentionwww.headneckonco.ruwww.headneckonco.ru